We discovered notable variations in CXCR5 DNA methylation levels across patients with RA and SLE compared with HC, indicating that CXCR5 methylation status may contribute to the pathophysiology of these autoimmune disorders. The gene discussed is CXCR5; the disease is autoimmune disease.